Rocket Pharmaceuticals, Inc.
RCKT
$6.36
-$0.64-9.14%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 318.16M | 372.34M | 235.66M | 278.83M | 330.31M |
| Total Receivables | -- | -- | -- | 8.10M | 8.60M |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 6.33M | 5.85M | 6.09M | 5.80M | 6.25M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 324.49M | 378.18M | 241.75M | 292.73M | 345.16M |
|
|
|||||
| Total Current Assets | 324.49M | 378.18M | 241.75M | 292.73M | 345.16M |
| Net Property, Plant & Equipment | 80.39M | 83.32M | 85.77M | 87.54M | 88.08M |
| Long-term Investments | 39.15M | 39.15M | 39.15M | 39.15M | 39.15M |
| Goodwill | 39.15M | 39.15M | 39.15M | 39.15M | 39.15M |
| Total Other Intangibles | 25.15M | 25.15M | 25.15M | 25.15M | 25.15M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 1.88M | 1.89M | 1.87M | 1.84M | 1.90M |
| Total Assets | 471.07M | 527.70M | 393.69M | 446.41M | 499.44M |
|
|
|||||
| Total Accounts Payable | 2.95M | 1.63M | 2.77M | 3.06M | 2.75M |
| Total Accrued Expenses | 29.44M | 36.02M | 34.10M | 30.64M | 26.41M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 2.88M | 2.86M | 2.85M | 2.86M | 2.87M |
| Total Finance Division Other Current Liabilities | 51.00K | 185.00K | 265.00K | 1.04M | 923.00K |
| Total Other Current Liabilities | 51.00K | 185.00K | 265.00K | 1.04M | 923.00K |
| Total Current Liabilities | 35.31M | 40.68M | 39.98M | 37.59M | 32.96M |
|
|
|||||
| Total Current Liabilities | 35.31M | 40.68M | 39.98M | 37.59M | 32.96M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 22.48M | 22.64M | 22.80M | 22.94M | 23.08M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 1.14M | 1.14M | 1.14M | 1.25M | 1.91M |
| Total Liabilities | 58.93M | 64.47M | 63.92M | 61.78M | 57.94M |
|
|
|||||
| Common Stock & APIC | 1.69B | 1.68B | 1.49B | 1.48B | 1.46B |
| Retained Earnings | -1.28B | -1.22B | -1.16B | -1.09B | -1.02B |
| Treasury Stock & Other | -27.00K | 66.00K | 213.00K | -218.00K | -135.00K |
| Total Common Equity | 412.14M | 463.23M | 329.77M | 384.64M | 441.50M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 412.14M | 463.23M | 329.77M | 384.64M | 441.50M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 412.14M | 463.23M | 329.77M | 384.64M | 441.50M |
|
|
|||||